Are Wall Street analysts bullish on Moderna stock?

view original post

Cambridge, Massachusetts-based Moderna, Inc. (MRNA) is a biotechnology company that provides messenger RNA medicines. Valued at a market cap of $17.2 billion, the company gained global prominence with …